In the news release, Decibel Reports Third Quarter 2026 Results: Quarterly Revenue Grows 7% YoY to $35.1 Million, International Sales Reach Record $12.1 Million, Reaffirms Full Year Outlook, issued 19-Nov-2026 by Decibel Cannabis Company Inc. over PR Newswire, we are advised by the company that changes have been made. The complete, corrected release follows, with additional details at the end:
Decibel Reports Third Quarter 2026 Results: Quarterly Revenue Grows 7% YoY to $35.1 Million, International Sales Reach Record $12.1 Million, Reaffirms Full Year Outlook
CALGARY, AB, Nov. 19, 2026 /CNW/ -- Decibel Cannabis Company Inc. (the "Company" or "Decibel") (TSXV: DB) (OTCQB: DBCCF), a leading Canadian branded cannabis company with a growing international platform, today announced its financial results for the three and nine month periods ended September 30, 2026.
"International delivered its third consecutive record quarter, with sales up 44% to $12.1 million. Gross margin before fair value adjustments expanded 500 basis points to 52%, reflecting our continued focus on driving efficiency. Domestic sales declined 6%. We have work to do in our domestic business and we are focused on giving each of our brands a distinct role, pricing and promoting with more discipline, and strengthening execution with our largest retail partners. With international scaling, a stronger balance sheet and a clear focus on domestic execution, we are well positioned to deliver our 2026 outlook and enter 2027 from a position of strength."
Benjamin Sze – Chief Executive Officer
Q3 2026 Highlights
- Net Revenue of $35.1 million, growth of 7% year over year
- Record International Sales of $12.1 million, growth of 44% year over year; year-to-date international sales of $32.3 million already exceed full-year 2025
- Gross Margin Before Fair Value Adjustments of 52%, an expansion of 500 basis points from Q3 2025
- Adjusted EBITDA(1) of $7.4 million
- Free Cash Flow(1) of $1.1 million
FY 2026 Outlook(2)
Decibel is reaffirming its 2026 full year guidance:
- Net Revenue of $132 to $137 million
- Adjusted EBITDA of $28 to $32 million
Notes: |
1 Non-GAAP financial measure. Refer to "Cautionary Statements – Non-GAAP Measures" for further details. |
2 The Company's outlook makes numerous assumptions. Assumptions used for the purposes of outlook may prove to be incorrect and actual results may differ from those anticipated. Refer to "Cautionary Statements – Preliminary Financial Information" for further details. |
International Update
Decibel's international sales grew 44% year over year to $12.1 million, a record and the third consecutive quarterly record. Sales rose 14% from the second quarter of 2026. Year over year growth has moderated from earlier quarters because AgMedica was already contributing in the Q3 2025 comparison period. Year to date international sales of $32.3 million already exceed all of 2025. Decibel expects to experience continued strong sequential growth through the balance of the year as the Company converts its existing backlog to revenue. We continue to believe international sales are positioned for significantly high double-digit growth through 2026, supported by the following Q3 2026 milestones:
- Announced agreement with Hilltop Leaf Ltd. for the launch of General Admission and Standard Issue flower portfolios in the United Kingdom across fifteen product lines, alongside six Hilltop Leaf branded product lines in Q4 2026. Received initial order for launch and working towards first shipment.
- 20+ international customers with executed supply agreements
- 70+ GACP cultivators and extractors onboarded
- 60 tons per annum of flower processing capacity at ~42% utilization based on Q3 2026 results
- AgMedica's EU GMP facility is designed to accommodate a doubling of current processing capacity without material capital investment, providing headroom to support continued international growth
- Expanding production of EU GMP extracts to meet growing demand, allowing for ease of access into vapes and oils, with ongoing shipments into multiple countries
- Anticipated expansion into three new international markets within the next six months
Domestic Update
Decibel's domestic sales declined 6% year over year to $23.0 million. The decrease reflected a reduction in infused products as a proportion of the overall cannabis market, with lower General Admission sales partly offset by growth in Standard Issue. Year to date domestic sales were $68.3 million, an increase of 2%. Management is focused on rebuilding domestic momentum through three priorities: giving each of its brands a distinct role in the portfolio, pricing and promoting with more discipline, and strengthening execution with its largest retail partners. The Company is also adding flower and standard pre-rolls, categories that have been gaps in its portfolio for a long time. Independent retailers are a specific area of focus, where there is meaningful opportunity to grow share through deeper engagement and more disciplined coverage. Q3 2026 milestones based on HiFyre data:
- Overall market share in Q3 2026 was 4.0% based on HiFyre data, down from 4.3% in Q2
- Decibel is the 4th largest LP in the pre-roll category with 6.1% market share and the 4th largest LP in the vape category with 8.4% market share.
- General Admission holds the #2 position in the fastest growing segments of liquid diamonds in both 510 and AIOs, while Standard Issue holds the #2 position in the distillate 1g 510 segment
- General Admission the #4 vape brand overall (4.5% share) and remains the #1 infused pre-roll brand (16.2%).
- Standard Issue is #6 overall in the vape category (3.0% share) and #7 overall in infused pre-roll (3.2% share)
Capital Allocation and NCIB
The Company has initiated steps to get an NCIB available. The Board does not currently anticipate material activity under the NCIB in the near term and will continue to assess share repurchases as part of its ongoing capital allocation framework, alongside continued investment in domestic and international growth.
Third Quarter Highlights
- Net Revenue was $35.1 million, a year over year increase of 7%. Net revenue growth was driven by continued growth in international demand. Year to date net revenue was $100.6 million, an increase of 20%.
- Domestic Sales were $23.0 million, a year over year decrease of 6%. The decrease reflected a reduction in infused products as a proportion of the overall cannabis market, with lower General Admission sales partly offset by growth in Standard Issue. Year to date domestic sales were $68.3 million, an increase of 2%.
- International Sales were $12.1 million, a year over year increase of 44%. The increase in international sales was driven by strong volume growth and high demand for the Company's flower and extract products, with the Company's customer backlog persisting as new contracts were signed and additional cross-selling to existing customers and suppliers. Year to date international sales were $32.3 million, an increase of 92%.
- Gross Margin Before Fair Value Adjustments was 52% in the third quarter of 2026, compared to 47% in the third quarter of 2025, primarily reflecting improvements in international gross margin, which the Company expects will continue to grow over time. Gross margin is expected to vary quarter to quarter based on product and channel mix, including the relative weighting of international wholesale, EU GMP extracts, and domestic recreational sales.
- Adjusted EBITDA(1) of $7.4 million, a year over year increase of 2%. The increase in Adjusted EBITDA for the quarter was primarily a result of net revenue growth outpacing spending, largely driven by international sales growth. Year to date Adjusted EBITDA was $22.2 million, an increase of 30%.
- Free Cash Flow(1) of $1.1 million, a year over year decrease of 31%. Year to date Free Cash Flow was ($8.7) million, primarily attributable to a $17.8 million increase in receivables and an $8.3 million reduction in payables, which was one-time in nature and resulted from the Company's debt refinancing.
- Adjusted Net Income(1) of $3.3 million, or $0.09 per share, a year over year decrease of 11%. Year to date Adjusted Net Income was $10.7 million, or $0.27 per share, an increase of 51%.
- Net Income of $3.8 million, or $0.10 per share, compared to a net loss of $1.3 million, or ($0.03) per share, in the third quarter of 2025.
Note: |
1 Non-GAAP financial measure. Refer to "Cautionary Statements – Non-GAAP Measures" for further details. |
Summary Highlights
Three months ended | Nine months ended | |||
September 30 | September 30 | |||
2026 | 2025 | 2026 | 2025 | |
(thousands of Canadian dollars, except where noted) | ||||
Gross Canadian recreational sales1 | $36,422 | $38,970 | $108,347 | $106,587 |
Net Canadian recreational sales1 | $23,001 | $24,505 | $68,281 | $67,212 |
International sales1 | $12,127 | $8,407 | $32,287 | $16,783 |
Total | ||||
Gross revenue | $48,549 | $47,377 | $140,634 | $123,370 |
Net revenue | $35,128 | $32,912 | $100,568 | $83,995 |
Gross profit before fair value adjustments | $18,252 | $15,360 | $51,486 | $39,981 |
Gross margin before fair value adjustments | 52 % | 47 % | 51 % | 48 % |
Adjusted EBITDA3 | $7,439 | $7,268 | $22,154 | $17,030 |
Net income (loss) and comprehensive income (loss) | $3,828 | ($1,340) | $5,830 | ($1,595) |
Adjusted net income3 | $3,341 | $3,757 | $10,651 | $7,057 |
Cash flow (used in) from continuing operations | $1,182 | $1,770 | ($7,605) | $3,742 |
Free cash flow2, 3 | $1,054 | $1,533 | ($8,703) | $2,497 |
Per Share Metrics | ||||
(Loss) income per share | $0.10 | ($0.03) | $0.15 | ($0.04) |
Adjusted EPS3 | $0.09 | $0.10 | $0.27 | $0.18 |
1 Supplementary financial measure. Refer to "Cautionary Statements – Non-GAAP Measures" for further details. |
2 Non-GAAP financial measure. Refer to "Cautionary Statements – Non-GAAP Measures" for further details. |
3 Non-GAAP ratio. Refer to "Cautionary Statements – Non-GAAP Ratios" for further details |
Decibel's condensed consolidated interim financial statements for the three and nine months ended September 30, 2026 and 2025 (the "Financial Statements") and related management's discussion and analysis are available on SEDAR+ under the Company's profile at www.sedarplus.ca.
The Company will host a live conference call to discuss the results at 11:00 a.m. ET today. To instantly join the conference call by phone, please use the following link to easily register close to the call start time. After registering, the system will call you instantly and connect you into the conference call automatically:
https://registrations.events/easyconnect/4359901/recRAX3XTbqFTjWUy/
Alternatively, you may dial in to the conference call to be connected by an Operator by calling 1(800) 715-9871 for Canadian participants and 1(888) 880-3330 for U.S. participants, referencing conference ID 4359901.
About Decibel
Decibel is a consumer-focused cannabis company with a strong foundation in the Canadian adult-use market, built on leading brands including General Admission, Qwest and Standard Issue. The Company focuses on disciplined innovation, consistent product quality and strong brand execution. Alongside its leadership position in Canada, Decibel is a significant and growing participant in international cannabis markets. Decibel operates a processing and manufacturing facility in Calgary, Alberta, a cultivation facility in Battleford, Saskatchewan, and an EU GMP licensed cultivation and processing facility in Chatham, Ontario.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.
Cautionary Statements
Shareholder Letter
The letter includes non-GAAP measures and forward-looking information and statements. Such measures and forward-looking information are subject to the same definitions, explanations, reconciliations, assumptions, risk factors, qualifications and disclaimers as are set out in this news release under the headings "Cautionary Statements – Non-GAAP Measures", "Non-GAAP Ratios", "Supplementary Financial Measures", "Forward-Looking Statements" and "Preliminary Financial Information", and readers should refer to those sections, which apply to the letter as if set out in full in it.
Non-GAAP Measures
This news release contains certain financial performance measures, namely Adjusted EBITDA, Adjusted Net Income and Free Cash Flow, that are not recognized or defined under IFRS (termed "Non-GAAP Measures"). As a result, this data may not be comparable to data presented by other licensed producers and cannabis companies. For an explanation of these measures to related comparable financial information presented in the Financial Statements prepared in accordance with IFRS, refer to the discussion below. The Company believes that these Non-GAAP Measures are useful indicators of operating performance and are specifically used by management to assess the financial and operational performance of the Company. Accordingly, these Non-GAAP Measures are intended to provide additional information and should not be considered in isolation or as a substitute for measures of performance prepared in accordance with IFRS.
Adjusted EBITDA is a Non-GAAP Measure that is calculated as net income (loss) and comprehensive income (loss) excluding unrealized gain on changes in fair value of biological assets, change in fair value of biological assets realized through inventory sold, depreciation and amortization expense, share-based compensation, other income, finance costs, foreign exchange loss, non-cash production costs and severance payments. Non-cash production costs relate to amortization expense allocations included in production costs. This Non-GAAP Measure should be considered together with other financial information prepared in accordance with IFRS to enable investors to evaluate Decibel's operating results, underlying performance and prospects in a manner similar to Decibel's management.
Three months ended | Nine months ended | |||
September 30 | September 30 | |||
2026 | 2025 | 2026 | 2025 | |
(thousands of Canadian dollars) | ||||
Net income (loss) and comprehensive income (loss) | 3,828 | (1,340) | 5,830 | (1,595) |
Unrealized gain on changes in fair value of biological assets | (3,764) | (4,463) | (12,023) | (14,142) |
Change in fair value of biological assets realized through inventory sold | 3,277 | 9,560 | 12,779 | 22,794 |
Depreciation and amortization | 1,495 | 1,676 | 4,573 | 4,972 |
Share-based compensation (recovery) | (16) | 478 | 724 | 832 |
Other loss (income) | 798 | (357) | 720 | (364) |
Finance costs | 1,201 | 661 | 3,431 | 2,022 |
Foreign exchange loss | 127 | 115 | 404 | 263 |
Non-cash cost of goods sold1 | 476 | 680 | 1,506 | 1,989 |
Other adjustments2 | 17 | 258 | 4,210 | 259 |
Adjusted EBITDA3 | 7,439 | 7,268 | 22,154 | 17,030 |
Adjusted Net Income is a Non-GAAP Measure that is calculated as net income (loss) and comprehensive income (loss) excluding unrealized gain on changes in fair value of biological assets and change in fair value of biological assets realized through inventory sold.
Three months ended | Nine months ended | |||
September 30 | September 30 | |||
2026 | 2025 | 2026 | 2025 | |
(thousands of Canadian dollars) | ||||
Net Income (loss) and comprehensive income (loss) | 3,828 | (1,340) | 5,830 | (1,595) |
Unrealized gain on changes in fair value of biological assets | (3,764) | (4,463) | (12,023) | (14,142) |
Change in fair value of biological assets realized through inventory sold | 3,277 | 9,560 | 12,779 | 22,794 |
Other adjustments | - | - | 4,065 | - |
Adjusted net income 1 | 3,341 | 3,757 | 10,651 | 7,057 |
Weighted average number of shares outstanding | 39,021,232 | 38,457,410 | 39,043,713 | 38,599,043 |
Adjusted EPS | $0.09 | $0.10 | $0.27 | $0.18 |
These measures are intended to provide a proxy for the Company's net income (loss) and comprehensive income (loss) and are used to compare Decibel to its competitors and derive expectations of future financial performance of the Company and should be considered together with other financial information prepared in accordance with IFRS to enable investors to evaluate Decibel's operating results, underlying performance and prospects in a manner similar to Decibel's management.
Free Cash Flow is a Non-GAAP Measure that is calculated as cash flow from operations less cash provided by (used in) investing activities. This Non-GAAP Measure should be considered together with other financial information prepared in accordance with IFRS to enable investors to evaluate Decibel's operating results, underlying performance and prospects in a manner similar to Decibel's management.
Three months ended | Nine months ended | |||
September 30 | September 30 | |||
2026 | 2025 | 2026 | 2025 | |
(thousands of Canadian dollars) | ||||
Cash (used in) provided by continuing operating activities | 1,182 | 1,770 | (7,605) | 3,742 |
Cash used in investing activities | (128) | (237) | (1,098) | (1,245) |
Free cash flow1 | 1,054 | 1,533 | (8,703) | 2,497 |
Non-GAAP Ratios
Adjusted EPS, or adjusted earnings per share, is a non-GAAP ratio, does not have a standardized meaning prescribed by GAAP and is therefore unlikely to be comparable to similar measures presented by other issuers. Adjusted EPS is calculated as net income (loss) and comprehensive income (loss) excluding unrealized gain on changes in fair value of biological assets and change in fair value of biological assets realized through inventory sold, divided by the weighted average common shares outstanding. The Company believes that adjusted earnings per share is a useful metric to normalize net income for biological asset accounting impacts.
Supplementary Financial Measures
International Sales is a supplementary financial measure intended to provide a more accurate depiction of international sales earned by the Company's wholesale operations.
Gross Canadian Recreational Sales is a supplementary financial measure intended to provide a more accurate depiction of gross revenue earned by the Company's wholesale operations.
Net Canadian Recreational Sales is a supplementary financial measure intended to provide a more accurate depiction of net revenue earned by the Company's wholesale operations.
Forward-Looking Statements
This news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release.
Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as "expects", or "does not expect", "is expected", "anticipates" or "does not anticipate", "plans", "budget", "scheduled", "forecasts", "estimates", "believes" or "intends" or variations of such words and phrases or stating that certain actions, events or results "may" or "could", "would", "might" or "will" be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements.
In this news release, forward-looking statements relate to, among other things: expectations relating to the scaling of international sales and management's belief that significant opportunity lies ahead for Decibel's operations, expectations that demand for Decibel's products will grow; the ability of Decibel to extend its product offering to new countries and create a global footprint, including anticipation of incremental international volumes, new contracts, new GACP cultivators onboarded, increasing value-add services, and the anticipated contributions from these activities, and the timing thereof; statements relating to the expansion of production of EU GMP extracts to meet increasing demand; statements relating to Decibel's expectations that demand will increase generally; statements regarding Decibel's expectation that international gross margins will continue to grow over time; expectations and statements relating to Decibel's position in the vape category and continued growth under this category; expectations and statements regarding the Share Consolidation, including expectations of the benefits of the Share Consolidation; Decibel's decisions regarding the NCIB and any expectations that the NCIB will occur in 2026 or at all; Decibel's expectation and belief that international sales are positioned for significantly high double-digit growth through 2026; expectations around the Company's full year outlook; the Company's marketing efforts and brand expansion, and the expected benefits therefrom; and its other business plans and expectations. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on the forward-looking statements contained in this news release. Except as required by law, the Company assumes no obligation to update the forward-looking statements of beliefs, opinions, projections or other factors should they change, except as required by law.
Forward-looking statements and FOFI (as defined herein) are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: risks relating to delays, regulatory changes and impacts; capital requirements; the ability to obtain and maintain licences to retail cannabis products; the ability to successfully market and sell its products domestically and internationally; the ability for the Company to continue successful relationships with international customers and GACP cultivators; review of the Company's production facilities by Health Canada and maintenance of licences (including any amendments thereto) from Health Canada in respect thereof; future legislative and regulatory developments involving cannabis; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the labour market generally and the ability to access, hire and retain employees; general business, economic, competitive, political and social uncertainties; including the imposition of levies and tariffs, and the general impact of such policies on the broader economy; the risk that the Company may not be able to meet consumer demand; the risk that the Company may not improve its operational capacity when anticipated or at all; the risk that Decibel may not remain in compliance with its financial covenants for the remainder of its twelve-month forecast period; the risk that the anticipated benefits of the Share Consolidation will not be realized by the Company and/or the effect of the Share Consolidation may harm the Company's share price and liquidity, market image or its ability to attract further investment, employees or service providers; the risk that the Company's Board may determine not to implement the NCIB in 2026 or at all; and the delay or failure to receive Board, regulatory or other approvals, including any approvals of the TSXV, as applicable. Many of these risks and uncertainties and additional risk factors are described in the Company's MD&A for the year ended December 31, 2025 and its MD&A for the three and nine months ended September 30, 2026, which are both available under the Company's profile at www.sedarplus.ca.
With respect to forward-looking statements and FOFI contained in this news release, Decibel has made assumptions regarding, but not limited to: growth of the brand and recognition in Canada will lead to growth internationally; demand for Decibel's products; the benefits of the Share Consolidation; the proposed benefits of implementing the NCIB; Decibel's ability to enter new markets and industry verticals; Decibel's ability to attract, develop and retain key personnel; Decibel's ability to raise additional capital and to execute on its expansion plans; the timelines for new product launches; Decibel's ability to continue investing in infrastructure and implement scalable controls, systems and processes to support its growth; the impact of competition; the changes and trends in Decibel's industry or the global economy; the Company's ability to generate sufficient cash flow from operations and obtain financing, if needed, on acceptable terms or at all; the general economic, financial market, regulatory and political conditions in which the Company operates; the ability of the Company to ship its products and maintain supply chain stability; the continued relationships with the Company's international customers and GACP cultivators, and the successful expansion of EU GMP extracts and related growing demand for such extracts; consumer interest in the Company's products; anticipated and unanticipated costs; government regulation of the Company's activities and products; the timely receipt of any required regulatory approvals; the Company's ability to conduct operations in a safe, efficient and effective manner; the Company's construction plans and timeframe for completion of such plans; and the changes in laws, rules, regulations, and global standards.
Readers are cautioned that the foregoing list of assumptions and risk factors is not exhaustive. The forward-looking statements contained herein are expressly qualified in their entirety by this cautionary statement. The forward-looking statements included in this news release are made as of the date hereof and Decibel does not undertake any obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless so required by applicable securities laws.
Preliminary Financial Information
Any financial outlook or future oriented financial information (in each case "FOFI") contained in this news release regarding the Company's prospective financial position, including, but not limited to Net Revenue, international sales and Adjusted EBITDA projections relating to full year 2026 guidance in this news release, is based on reasonable assumptions about future events, including those described above, based on an assessment by management of Company of the relevant information that is currently available.
The Company's anticipated financial results, including, but not limited to, Net Revenue, international sales and Adjusted EBITDA (see "Non-GAAP Measures" above) assumes, among other things: (i) relative stability in interest rates; (ii) limited relative deterioration in foreign exchange rates due to ongoing and evolving trade and tariff policies; (iii) limited overall impact to the Company's costs resulting from trade and tariff policies and from other geopolitical factors, including conflict in the Middle East; (iv) limited overall impact to domestic and international demand for our products resulting from the broader economic impacts from trade and tariff policies, and related uncertainty; (v) the Company's ability to execute its domestic portfolio and pricing plan and rebuild the quality of its domestic revenue; (vi) the performance of domestic sales for the Company's products, including, but not limited to, the Standard Issue, General Admission and Qwest brands and the vape portfolio; and (vii) the Company's international outlook, including, but not limited to, its ability to maintain its international customers, GACP cultivators, flower processing capacity, and EUGMP extract demand. The actual results will likely vary from the amounts set forth herein and such variations may be material.
The Company's anticipated financial results are unaudited and preliminary estimates that: (i) represent the most current information available to management as of the date of this news release; (ii) are subject to completion review and audit procedures that could result in significant changes to the estimated amounts; and (iii) do not present all information necessary for an understanding of the Company's financial condition as of, and the Company's results of operations for, such periods. The anticipated financial results are subject to the same limitations and risks as discussed under "– Forward-Looking Statements" above. Accordingly, the Company's anticipated financial results for such periods may change upon the completion and approval and audit of the financial statements for such periods and the changes could be material.
Correction: An earlier version of this release incorrectly included a non working link, the paragraph including the link was deleted from the release.
SOURCE Decibel Cannabis Company Inc.

For More Information Contact: Decibel Cannabis Company Inc., [email protected], 1-844-993-4769
Share this article